GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (OTCPK:ONWRF) » Definitions » LT-Debt-to-Total-Asset

Onward Medical NV (Onward Medical NV) LT-Debt-to-Total-Asset : 0.37 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Onward Medical NV LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Onward Medical NV's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.37.

Onward Medical NV's long-term debt to total assets ratio increased from Dec. 2022 (0.18) to Dec. 2023 (0.37). It may suggest that Onward Medical NV is progressively becoming more dependent on debt to grow their business.


Onward Medical NV LT-Debt-to-Total-Asset Historical Data

The historical data trend for Onward Medical NV's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV LT-Debt-to-Total-Asset Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 1.44 2.95 0.13 0.18 0.37

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.15 0.18 0.26 0.37

Onward Medical NV LT-Debt-to-Total-Asset Calculation

Onward Medical NV's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=17.782/47.578
=

Onward Medical NV's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=17.782/47.578
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (OTCPK:ONWRF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Onward Medical NV LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (Onward Medical NV) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (Onward Medical NV) Headlines

No Headlines